Duchenne clinical trials at University of California Health

1 in progress, 0 open to eligible people

Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping
Sorry, in progress, not accepting new patients
AOC 1044-CS2 (EXPLORE44-OLE) is an Open-label Study to Evaluate the Pharmacodynamics and Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants with Mutations Amenable to Exon 44 Skipping.
at UC Davis UCSD

Last updated: February 5, 2025